Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) discusses the process of mass-producing vaccines.

Moderna: 'We're Ready' To Ship 20 Million Coronavirus Vaccine Doses By The End Of 2020

Nathan Shapiro, MD, (Emergency Medicine, BIDMC) discusses a clinical trial to test a repurposed antiviral AIDS drug for at-home treatment during the first days of COVID-19 symptoms in hopes of slowing the virus early and heading off hospitalization, intensive care, and death.

Trial begins of at-home treatment that may keep early cases from growing severe

Nathan Shapiro, MD, (Emergency Medicine, BIDMC) discusses restaurants and the COVID-19 pandemic. Shapiro was one of the authors of a CDC study released in September that found that people who tested positive for COVID-19 were approximately twice as likely to have reported dining at a restaurant than those who tested negative.

Dining out is one of the riskiest things you can do—but it doesn’t have to be, if you follow these steps.

Katheryn Stephenson, MD, MPH discusses the timeline for COVID-19 vaccine clinical trials

Some Americans concerned about possible ...

Satchit Balsari, MD (Emergency Medicine, BIDMC) discusses how mobility data could be used to fight COVID-19, and notes that the region is on the move again compared to the beginning of the pandemic.

WCVB – October 26, 2020

The clinical trial for Johnson & Johnson’s COVID-19 vaccine has restarted after pausing for potential safety concerns after confirming that there was no evidence of harm from the vaccine candidate.

Covid-19 vaccine trials from AstraZeneca, Johnson & Johnson to restart

Should COVID still force us to postpone elective surgery or forgo a trip to the ER?

In this opinion article, the author references a study released earlier in the year led by Dhruv Kazi, MD, MSc, MS (Cardiology, BIDMC) that quantified the effect of the COVID-19 pandemic on the numbers of patients seeking medical attention for select potentially life-threatening diagnoses.

The vaccine news that really matters

Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) discusses COVID-19 vaccine development.

National Academy of Medicine elects 9 HMS faculty members

Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) was elected to the National Academy of Medicine for being an international leader in virology and immunology, developing novel vaccines and cure strategies for viruses of global importance, including one of the first COVID-19 vaccine candidates, the first Zika virus vaccine, and the first global mosaic HIV-1 vaccine, as well as defining immunotherapeutic HIV-1 cure strategies.